Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference14 articles.
1. Preoperative chemotherapy for Stage IIIa (N2) lung cancer;Martini;Ann Thorac Surg,1993
2. Significance of positive superior mediastinal lymph nodes identified at mediastinoscopy in patients with resectable cancer of the lung;Pearson;J Thorac Cardiovasc Surg,1982
3. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer;Sause;Chest,2000
4. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer;Rosell;N Engl J Med,1994
5. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer;Roth;J Natl Cancer Inst,1994
Cited by 109 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum;Current Oncology Reports;2024-01-02
2. Sufficient Multidisciplinary Discussion Can Make Patients’ Outcomes Better in the Treatment for Stage III Non–Small-Cell Lung Carcinoma - Reply to Ohri et al.;Clinical Lung Cancer;2023-11
3. Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer;Siberian journal of oncology;2022-12-28
4. Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars;Expert Review of Anticancer Therapy;2022-04-25
5. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials;ESMO Open;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3